Evolocumab Effects on Lipoproteins, Measured by High-Performance Liquid Chromatography-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evolocumab Effects on Lipoproteins, Measured by High-Performance Liquid Chromatography

Published:2020-11-01 Issue:11 Volume:27 Page:1183-1207
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Masuda Daisaku¹²,Kiyosue Arihiro³⁴,Hirayama Atsushi⁵,Shimauchi Junichiro⁶,López J. Antonio G.⁷,Miyawaki Kazumasa⁶,Yamashita Shizuya¹⁸⁹

Affiliation:

1. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine

2. Rinku Innovation Center for Wellness Care and Activities (RICWA), Rinku General Medical Center

3. Department of Cardiovascular Medicine, University of Tokyo Hospital

4. Tokyo-Eki Center-building Clinic

5. Division of Cardiology, Osaka Police Hospital

6. Amgen Astellas BioPharma K.K.

7. Global Development, Amgen, Inc.

8. Department of Community Medicine, Osaka University Graduate School of Medicine

9. Department of Cardiology, Rinku General Medical Center

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/27/11/27_54353/_pdf

Reference32 articles.

1. 1) Cannon CP, Steinberg BA, Murphy SA, Mega JL and Braunwald E: Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol, 2006; 48: 438-445

2. 2) Aday AW, Lawler PR, Cook NR, Ridker PM, Mora S and Pradhan AD: Lipoprotein particle profiles, standard lipids, and peripheral artery disease incidence. Circulation, 2018; 138: 2330-2341

3. 3) Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC, Virani SS, Williams KA, Yeboah J and Ziaeian B: 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol, 2019; 74: e177-e232

4. 4) Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S and Kannel WB: Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA, 1986; 256: 2835-2838

5. 6) Gardner CD, Fortmann SP and Krauss RM: Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA, 1996; 276: 875-881

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electrochemical Biosensor for the detection of low density lipoprotein based on gold nanoparticles mediated bi-enzymes catalytic silver deposition reaction;Microchemical Journal;2024-04

2. Remnant cholesterol but not LDL cholesterol is associated with 5-year bleeding following percutaneous coronary intervention;iScience;2023-10

3. Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate;Journal of Atherosclerosis and Thrombosis;2021-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3